Patent Assignment
Reel/Frame 072160/0110
Assignment of Assignor's Interest
Recorded: 2025-09-04
Pages: 7
Assignor
NAVIRE PHARMA, INC.
Executed: 2025-09-03
Assignee
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
210 WEST 7TH ST., AUSTIN, TEXAS, 78701
Covered Properties
(3)
PTPN11 Inhibitors
PTPN11 Inhibitors
PTPN11 Inhibitors
Application:
18/799,303 →
Publication:
US 2025/0188074
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 19, 2019
From: JONES, PHILIP; CZAKO, BARBARA; CARROLL, CHRISTOPHER L.; MANDAL, PIJUS
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050093/0189 →
Assignment of Assignor's Interest
Oct 21, 2020
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 054130/0519 →
Assignment of Assignor's Interest
Oct 26, 2021
From: JONES, PHILIP; CZAKO, BARBARA; CARROLL, CHRISTOPHER L.; MANDAL, PIJUS
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 057919/0429 →
Assignment of Assignor's Interest
Oct 26, 2021
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 057919/0638 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →